Color Study (High-Risk Breast Lesions)

Purpose of this Study

If you choose to join this study, you will:<ul>
<li>Give a saliva sample</li>
<li>Have a genetic test using the Color Genomics 30 gene hereditary panel test</li></ul>

Who Can Participate?

Eligibility

Women diagnosed with high-risk breast lesions, which include:<ul>
<li>Lobular carcinoma in situ (LCIS)</li>
<li>Atypical ductal hyperplasia (ADH)</li>
<li>Atypical lobular hyperplasia (ALH)</li>
<li>Flat epithelial atypia (FEA)</li>
<li>Columnar cell hyperplasia (CCH)</li></ul>

Age Range

18-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

We are doing this study to screen women diagnosed with high-risk breast lesions for genetic mutations that may be linked to a future risk of cancer.

Locations

Remote/online

Compensation

No

Spanish Materials Available

No

Study Details

Full Title

Genetic testing for women with high-risk breast lesions

Principal Investigator

Jennifer
Plichta

Protocol Number

PRO00089223

NCT ID

NCT00000000

Phase

N/A

Enrollment Status

Open to Enrollment